17-1709501-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001164407.2(TLCD2):c.340G>T(p.Val114Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000195 in 1,536,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 18/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164407.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLCD2 | NM_001164407.2 | c.340G>T | p.Val114Leu | missense_variant, splice_region_variant | 3/4 | ENST00000330676.8 | NP_001157879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLCD2 | ENST00000330676.8 | c.340G>T | p.Val114Leu | missense_variant, splice_region_variant | 3/4 | 2 | NM_001164407.2 | ENSP00000331965 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151848Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1384728Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 683304
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151848Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74106
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2024 | The c.340G>T (p.V114L) alteration is located in exon 3 (coding exon 3) of the TLCD2 gene. This alteration results from a G to T substitution at nucleotide position 340, causing the valine (V) at amino acid position 114 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at